Imaging for Neurological Disease: Current Status
and New Developments
Stanley van den Noort, Elliot Frohman, and Teresa Frohman, University of California,
Irvine
The Journal of Mind and Behavior , Summer 1988, Vol. 9, No. 3, Pages 221
[1]-226 [6], ISSN 0271-0137, ISBN 0-930195-03-5
Approximately a century ago we were in the process of discrediting phrenology which
attempted to predict behavior on the basis of the shape of the skull. With the advent
of x-ray it was possible to detect fractures, tumors and infections which altered
the structure of bone, and to use the frequently calcified pineal gland as a marker
of shifts in the intracranial structures. In the years surrounding World War I we
learned to use the introduction of air in the cerebrospinal fluid to achieve x-ray
contrast for the definition of intracranial contents. Just prior to World War II
came the ability to visualize the arteries and veins of the head by arterial injection
of x-ray opaque substances; similar agents were injected into the cerebrospinal fluid.
Over time these techniques gained in sophistication and safety but were associated
with substantial limitations of accuracy, risk, and discomfort. The advent of computerized
tomographic (CT) radiography of the skull and spine in the 1970s provoked a real
revolution in the speed, accuracy, and safety of neurological diagnosis. Now magnetic
resonance imaging (MRI) provides better accuracy and safety without an improvement
in speed. Other technologies beckon and it is hard for any of us to confidently predict
the future.
Requests for reprints should be sent to Stanley van den Noort, M.D., Department
of Neurology, California College of Medicine, University, of California, Irvine,
California 92717.
The Radiological Diagnosis of Primary Brain Tumours
Henry F.W. Pribram, University of California, Irvine Medical Center
The Journal of Mind and Behavior , Summer 1988, Vol. 9, No. 3, Pages 227
[7]-240 [20], ISSN 0271-0137, ISBN 0-930195-03-5
The investigation of primary brain tumours has changed dramatically as a result of
the development of Computed Tomography and Magnetic Resonance Imaging. Computed Tomography
can be performed rapidly with little patient discomfort but artifacts degrade images
of the posterior fossa. Magnetic Resonance Imaging of the brain is a more sensitive
procedure but it is time consuming. In addition not all patients are cooperative
enough and some become claustrophobic in the scanner. Patients with cardiac pacemakers,
aneurysm clips or intraocular foreign bodies cannot be examined by MRI. These new
modalities allow earlier diagnosis with less risk to the patient. The impact of early
diagnosis in the treatment of malignant tumours is not clear, but in the case of
benign tumours it will reduce the morbidity from operation.
Requests for reprints should be sent to Henry F.W. Pribram, M.D., Professor of
Radiology and Neurology, University of California, Irvine Medical Center, 101 City
South Drive, Orange, California 92668.
Principles and Applications of Magnetic Resonance
Imaging (MRI) in Neurology and Neurosurgery
T.M. Peters, McConnell Brain Imaging Cantre and Montreal Neurological Institute
The Journal of Mind and Behavior , Summer 1988, Vol. 9, No. 3, Pages 241
[21]-262 [42], ISSN 0271-0137, ISBN 0-930195-03-5
Magnetic Resonance Imaging has evolved from NMR Spectroscopy, a chemical analysis
technique developed 40 years ago, into a sophisticated imaging modality which is
rapidly becoming a major factor in the diagnosis of brain disease. The technique
uses the properties of the interaction of certain spinning nuclei with applied magnetic
fields to observe the behavior of these nuclei after being stimulated by radio-frequency
radiation. Application of secondary (gradient) magnetic fields allows the spins to
be frequency encoded with respect to their position in an object. The radio frequency
signals produced by the spinning nuclei are detected and analysed by a computer to
form images. The sophisticated high field-strength magnets used in these systems
dictate that special provisions must be made for their installation in a hospital
environment. Specific examples of MR images are presented with respect to stereotactic
surgery planning, diagnosis of Multiple Sclerosis and spinal cord lesions, correlation
with other imaging modalities, and in-vivo phosphorous spectroscopy.
Requests for reprints should be sent to T.M. Peters, Ph.D., Room WB-316, Montreal
Neurological Institute, 3801 University Street, Montreal, Quebec H3A 2B4, Canada.
Functional Stereotactic Neurosurgery With Magnetic
Resonance Imaging Guidance
Ronald F. Young, University of California, Irvine
The Journal of Mind and Behavior , Summer 1988, Vol. 9, No. 3, Pages 263
[43]-272 [52], ISSN 0271-0137, ISBN 0-930195-03-5
The development of stereotactic surgery has been dependent upon concomitant advances
in brain imaging techniques. Human stereotactic surgery effectively began in 1950
with the advent of contrast ventriculography. The anatomy of the third ventricle
outlined by ventriculography was used as a reference to determine the location of
structures, within essentially normal brains, whose functions could be surgically
altered to favorably affect the course of certain neurological diseases. Such functional
neurosurgery has been employed most effectively in the treatment of movement disorders
such as Parkinson's disease and for surgery of intractable pain. Unfortunately, ventriculography
does not allow direct visualization of the target in the brain to be treated, thus
providing inaccuracies in target localization. Functional stereotactic guidance,
by computerized tomographic scan data, provides a near direct view of the brain,
but lack of resolution and radiation exposure limit its usefulness. Magnetic resonance
imaging guidance for stereotactic surgery offers the possibility of improved target
visualization and avoids radiation exposure. This report describes the author's prelimanary
experience using the Leksell stereotactic system and magnetic resonance imaging guidance
for the performance of functional stereotactic neurosurgery.
Requests for reprints should be sent to Ronald F. Young, M.D., Division of Neurological
Surgery, California College of Medicine, 101 City Drive South, University of California,
Irvine, California 92668.
Magnetic Resonance Imaging in Neuro-ophthalmology
Edward K. Wong, Jr. and Bradly P. Gardner, University of California, Irvine
The Journal of Mind and Behavior , Summer 1988, Vol. 9, No. 3, Pages 273
[53]-288 [68], ISSN 0271-0137, ISBN 0-930195-03-5
Magnetic Resonance Imaging (MRI) of the visual system is an important new diagnostic
technique used in neuro-ophthalmology. MRI has been used to detect intraocular and
orbital pathology complementary to computerized tomographic (CT) scanning and ultrasoundin the resolution of small anatomic structures. MRI has been able to demonstrate
with exquisite detail the complete visual and oculomotor pathways, from the eye to
the occipital lobe and brainstem. Laboratory studies involving MRI in both in
vitro and in vivo designs have attempted to elucidate the underlying
biochemical mechanism involved with specific disease processes. This may lead to
earlier detection of disease, with the potential for differentiation between specific
histopathologic tumor types through noninvasive means. Other studies are involved
with high energy phosphate metabolism sodium imaging, and hydration. MRI holds great
potential for the future as technology continues to advance with increasing magnetic
field strength and better techniques of resolution.
Requests for reprints should be sent to Bradley P. Gardner, M.D., 5453 Lasher
Road, Hidden Hills, California, 91302.
Use of Intraoperative Angiography in Neurosurgery
Leslie D. Cahan, California College of Medicine and Grant B. Hieshima, Randall T.
Higashida, Van V. Halbach, San Francisco School of Medicine, University of California
The Journal of Mind and Behavior , Summer 1988, Vol. 9, No. 3, Pages 289
[69]-298 [78], ISSN 0271-0137, ISBN 0-930195-03-5
Neurosurgeons have long recognized that interoperative angiography could be of significant
help to guide surgery for aneurysms, vascular malformations and intercranial anastomoses.
In recent years, the advent of portable digital subtraction angiography equipment
has allowed neurosurgeons to obtain high quality, rapid sequence cerebral angiograms
in the operating room. We have used this equipment to verify clip placement on aneurysms,
assess the excision of vascular malformations, and to guide injection of liquid adhesive
into arteriovenous malformations in the operating room. The expanded use of stereotaxic
surgery for functional and tumor work has also been facilitated in recent years by
CT and MR scanning. Stereotaxic neurosurgery can be modified to include angiography
so that risk of injury to intracerebral vessels will be lessened. Angiographic landmarkscan also be used to define intracerebral structures. In this paper, we will outline
the use of intraoperative angiography in open neurosurgical procedures as well as
its application to stereotaxic procedures.
Requests for reprints should be sent to Leslie D. Cahan, M. D., Division of Neurosurgery,
UCI Medical Center, 101 The City Drive South, Orange, California 92668.
Anatomical Definition in PET Using Superimposed
MR Images
Ranjan Duara, Anthony Apicella, David W. Smith, Jen Yueh Chang, William Barker, and
Fumihito Yoshii, Mount Sinai Medical Center, Miami Beach
The Journal of Mind and Behavior , Summer 1988, Vol. 9, No. 3, Pages 299
[79]-310 [90], ISSN 0271-0137, ISBN 0-930195-03-5
Techniques such as PET and SPECT provide tomographic images of function. These images
may also represent underlying structure, but to a variable extent, depending on the
type of physiological activity that is being imaged. MRI can provide images with
exquisite anatomical detail, and can potentially be used to define underlying structure
in PET and SPECT images of the brain. In the presence of anatomical distortion of
the brain or focal or global atrophy, existing methods for anatomical localization
(e.g., stereotactical localization) in functional images are deficient. We have developed
a method of superimposing MR images onto PET images in an objective fashion. Using
the outermost contour of the two images to derive, mathematically, the center of
mass and the major and minor axes, we obtain the translational and rotational parameters
to accomplish the superimposition of images. The aspect to this method that requires
the most attention to detail is the positioning of the patient in the two tomographic
devices and immobilization of the patient during the scans. We have obtained an estimate
of error of the superimposition process by performing phantom studies which revealed
an overall error of alignment for any poimt in the skull to be 1.54±0.8mm. We
have found this method to be convenient and accurate by visual inspection in a variety
of patients with dementia. The method also lends itself to such applications as correction
of measured isotope concentration for the effects of atrophy and for attenuation
correction of emmited photons.
Requests for reprints should be sent to Ranjan Duara, M.D., Section of Positron
Emission Tomography, Division of Nuclear Medicine, Mount Sinai Medical Center, 4300
Alton Road, Miami Beach, Florida 33140.
Neuroimaging of Head Injury
Maria Luisa Pasut and Sergio Turazzi, University Hospital, Verona
The Journal of Mind and Behavior , Summer 1988, Vol. 9, No. 3, Pages 311
[91]-350 [130], ISSN 0271-0137, ISBN 0-930195-03-5
Neuroimaging in head traumatology has received a decisive impulse with the advent
of computed tomoography (CT). CT scanning is noninvasive and therefore repeatable
as the need arises; it affords direct and accurate visualization of brain damage
at all stages, and permits intelligent planning of surgery for expanding lesions,
sometimes before such lesions produce neurological deterioration. Also, as a byproduct
of more realistic definition of traumatic brain damage, CT scanning has revealed
the obsolescence of classic neurotraumatological terminology as well as some reliable
correlations between different lesions and final outcome. Cerebral angiography, however,
retains its full value in vascular traumatic pathology and the rare cases of traumatic
aneurysm, which cannot be detected with certainty by CT scanning. Even newer methods
are positron-emission tomography (PET) and nuclear magnetic resonance (NMR), the
former yielding valuable information on brain tissue metabolism, the latter being
effective in differentiating gray matter from white and estimating their water contents.
Requests for reprints should be sent to Maria Luisa Pasut, M.D., Dipartimento
di Neurochirurgia, Istituti Ospitalieri, 37126 Verona, Italy.
Alzheimer's Disease, Dementia and Down Syndrome:
An Evaluation Using Positron Emmissions Tomography (PET)
Neal R. Cutler, Center for Aging and Alzheimer's and Prem K. Narang, Adria Labs,
Columbus, Ohio
The Journal of Mind and Behavior , Summer 1988, Vol. 9, No. 3, Pages 351
[131]-366 [146], ISSN 0271-0137, ISBN 0-930195-03-5
The assessment of brain metabolism using positron emission tomography (PET) and radioactive
tracers holds promise in the differential diagnosis and early detection of various
dementing disorders. Such research may also further our understanding of normal aging
and of underlying disease mechanisms in pathologic conditions. For example, PET measurement
of cerebral metabolic rates for glucose (CMRglc) appears to be a more sensitive indicator
of brain changes in Alzheimer's disease than cognitive and sensory tests. In Down's
syndrome patients, age-related decrements in CMRglc are seen that are consistent
with the neuropathologic changes associated with the disease; by contrast, CMRglc
appears to be age-invariant in normal subjects. Such assessments have also revealed
differences from normal controls among individuals at genetic risk for Huntington's
disease. These findings and other data on brain metabolism rates in the dementing
disorders are critically reviewed, and avenues for future research are suggested.
Requests for reprints should be sent to Neal R. Cutler, M.D., 8500 Wilshire Blvd.,
Lobby Suite, Beverly Hills, California 90211.
Neurotransmitter Receptor Imaging in Living
Human Brain with Positron Emmision Tomography
Stephen M. Stahl, Rosario Moratalla and Norman G. Bowery, Merck Sharp and Dohme Research
Laboratories
The Journal of Mind and Behavior , Summer 1988, Vol. 9, No. 3, Pages 367
[147]-384 [164], ISSN 0271-0137, ISBN 0-930195-03-5
New neuroimaging technology can label specific receptors in living human brain with
ligands tagged with radio-isotopes, and then anatomically localized and quantitate
them with positron emission tomography (PET). This approach requires a multidisciplinary
team, including radiochemists who prepare tagged ligands, pharmacologists who develop
in vitro and ex vivo techniques for quantitating receptors in experimental
animals, and PET experts who adapt these techniques for in vivo study of
human subjects. This article outlines the principles of quantitative PET anaylsis
by examining the numerous biochemical, kinetic and anatomical methods available for
neurotransmitter receptor quantitation in experimental animals, as well as their
applications to the study of neurotransmitter receptors in living human brain with
PET.
Requests for reprints should be sent to Stephen M. Stahl, M.D., Ph.D., Merck
Sharp and Dohme Research Laboratories, Neuroscience Research Centre, Terlings Park,
Eastwick Road, Harlow, Essex, CM20 2QR, United Kingdom.
SPECT Imaging in Alzheimer's Disease
B. Leanard Holman, Brigham and Women's Hospital, Keith A. Johnson, Massachusetts
General Hospital and Thomas C. Hill, New England Deaconness Hospital
The Journal of Mind and Behavior , Summer 1988, Vol. 9, No. 3, Pages 385
[165]-398 [178], ISSN 0271-0137, ISBN 0-930195-03-5
A number of radiotracers have recently been developed that accumulate in the brain
proportional to cerebral blood flow. These compounds are lipophilic, moving across
the blood-brain barrier with nearly complete extraction during a single passage through
the cerebral circulation. Once inside the brain, they are either bound to nonspecific
receptors or metabolized to nonlipophilic compounds. As a result, they maintain this
distribution within the brain for some time after injection. The development of these
commercially available tracers promises to bring into general medical practice the
remarkable diagnostic advances that have been limited to the small number of centers
that can afford the costly on-site cyclotrons and technical support required for
positron emission tomography. This review will describe the radiopharmaceuticals
and instrumentation which may be expected to provide useful clinical information
about cerebral perfusion, and will describe the authors' initial experience with
these techniques in memory disorder.
Requests for reprints should be sent to Leonard Halman, M.D., Department of Radiology,
Brigham and Women's Hospital, 75 Francis Street, Boston, Massachusettes 02115.
Ditigal Subtraction Angiography
John R. Hesselink and Steven M. Weindling, University of California Medical Center,
San Diego
The Journal of Mind and Behavior , Summer 1988, Vol. 9, No. 3, Pages 399
[179]-414 [194], ISSN 0271-0137, ISBN 0-930195-03-5
Digital subtraction angiography (DSA) brought the computer into the angiography suite.
With it came the capability of rapid subtraction angiography and post processing
of the images to optimize image contrast and brightness. DSA is a valuable adjunct
to conventional angiography and has added considerable flexibility to the angiographic
procedure. Using intravenous techniques, the extracranial carotid and vertebral arteries
can be imaged to assess the degree of atheromatous disease with reasonable consistency
and accuracy. Arterial DSA can image the intracranial circulation rapidly using smaller
doses of contrast material to reduce procedure time and the risk of a complication.
DSA is particularly helpful in those patients where severe atheromatous disease or
vessel tortuosity preclude selective catheterization. Conventional film angiography
remains the gold standard for cerebrovascular imaging.
Requests for reprints should be sent to John R. Hesselink, M.D., Department of
Radiology, UCSD Medical Center, 225 Dickinson Street, San Diego, California 92103.